Beam Therapeutics Inc (BEAM)

NASDAQ · Biotechnology

27.23
-1.61 (-5.58%)
Updated Oct 31, 11:24 PM ET
AI Rating
Hold
Overall Score
50
Trend
27
Momentum
74
Risk
52

Scores are generated from technical indicators for educational purposes and are not a recommendation to buy or sell.

Price history

Daily closes and volume
Oct 15, 2025 260 sessions Oct 27, 2026

AI Analysis

Beam Therapeutics Inc is trading at $27.23, down 5.58% on the session. The 50 day average sits at $25.91 and the 200 day at $28.23, which puts the stock in a downtrend. RSI is at 50.4, which reads as neutral, and MACD is bullish crossover. Volume is volume spike.

The nearest support is around $23.83 with resistance near $25.29, so that band frames the current range. Average daily movement is roughly $1.29, or about 4.7% of the share price, which is what any stop placement has to allow for. The overall health score of 50 out of 100 combines a trend score of 27, momentum of 74 and a risk score of 52.

Technical indicators

RSI (14)
50.4
neutral
MACD
-0.328
bullish crossover
SMA 20
24.60
SMA 50
25.91
SMA 200
28.23
downtrend
ATR (14)
1.29
avg daily range
Support
23.83
Resistance
25.29
Volume vs 20d
1.62x
volume spike
Volatility
46.8%
annualised
1 month
+2.77%
3 months
-4.30%

Stay Ahead of the Market

Get daily AI insights, market updates, and trade opportunities delivered to your inbox.